#AS­CO24: A roundup of the lat­est da­ta from Merus, Mor­phoSys and oth­ers

Read on for news about Im­muno­core, Ar­cus, CG On­col­o­gy, Gen­mab, Mer­ck and GSK:

Merus stock spikes on da­ta in head and neck squa­mous cell car­ci­no­ma …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.